You are required to be logged in to access the full website
Click here if you have forgotten your username or password
24 August 2026 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) disclosed on Monday that it has received Japan's first global approval for Hibsago (bepirovirsen) as a functional cure for chronic hepatitis B in adults who have received ...
24 August 2026 - South Korean pharmaceutical company Hanmi Pharm Co Ltd announced on Monday that it has entered into an exclusive licensing agreement with Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), for the development, manu...
24 August 2026 - Medical technology company Pulnovo Medical announced on Sunday the enrolment of the first two patients in its PULSE-LHD clinical trial, conducted under a US Food and Drug Administration (FDA) Investigational Device Exemption (IDE), a...
24 August 2026 - Rznomics Inc (KOSDAQ:476830), a South Korea-based biopharmaceutical company specialising in the development of RNA-based gene therapies, announced on Sunday that it is joining Lilly Gateway Labs (LGL) in San Diego, California.Lilly G...
24 August 2026 - Anbogen Therapeutics Inc (TPEx:7784), a Taiwan-based, clinical-stage precision oncology company, announced on Sunday that it has entered into a Collaborative Research Agreement (CRA) with the Laboratory of Veterinary Surgery, Graduat...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe